← FDA Drug Approvals (Drugs@FDA)
HALOBETASOL PROPIONATE AND TAZAROTENE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2025-05-02
Drug application
- FDA Application #
ANDA217190- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HALOBETASOL PROPIONATE AND TAZAROTENE
- Generic name
- Halobetasol Propionate
- Active ingredients
- HALOBETASOL PROPIONATE; TAZAROTENE
- Dosage form
- LOTION
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- SUN PHARMA CANADA
- First approval
- 2025-05-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown